Artificial Scaffolds and Mesenchymal Stem Cells for Hard Tissues - Tissue Engineering: Cell-Surface Interactions for Tissue Culture - page 186

the Center for international blood and marrow transplant research. J Clin Oncol 23:
5788-5794
7. Crisostomoto PR, Wang Y, Markel TA et al (2008) Human mesenchymal stem cells
stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B— but
not JNK-dependent mechanism. Am J Physiol Cell Physiol 294:675-682
8. Slayton WB, Spangrude GJ (2004) Adult stem cell plasticity. In: Turksen K (ed) Adult stem
cells. Humana Press, New Jersey, pp 1-3
9. Forte E, Chimenti I, Barile L et al (2011) Cardiac cell therapy: the next (re)generation. Stem
Cell Rev Rep. doi:10.1007/s12015-011-9252-8 [Epub ahead of print]
10. Mozid AM, Arnous S, Sammut EC et al (2011) Stem cell therapy for heart diseases. Br Med
Bull 98:143-159
11. Vanikar AV, Dave SD, Thakkar UG et al (2010) Cotransplantation of adipose tissue-derived
insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for
insulin-dependent diabetes mellitus. Stem Cells Int 2010:582382. 20 Dec 2010
12. Meng J, Muntoni F, Morgan JE (2011) Stem cells to treat muscular dystrophies—where are
we? Neuromuscul Disord 1:4-12
13. Illes J, Reimer JC, Kwon BK (2011) Stem cell clinical trials for spinal cord injury:
readiness, reluctance, redefinition. Stem Cell Rev Rep. doi:10.1007/s12015-011-9259-1
[Epub ahead of print]
14. Joe AW, Gregory-Evans K (2010) Mesenchymal stem cells and potential applications in
treating ocular disease. Curr Eye Res 35:941-52
15. Barranco C (2011) Stem cells: mesenchymal stem cells from adipose tissue could be used to
deliver gene therapy to the liver. Nat Rev Gastroenterol Hepatol 8:64
16. Liu T, Wang Y, Wen C, Zhang S et al (2011) Stem cells or macrophages, which contribute
to bone marrow cell therapy for liver cirrhosis? Hepatology. doi: 10.1002/hep.24431
17. Rhee YH, Ko JY, Chang MY et al (2011) Protein-based human iPS cells efficiently generate
functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest.
doi: 10.1172/JCI45794
18. Lindvall O, Kokaia Z (2010) Stem cells in human neurodegenerative disorders—time for
clinical translation. J Clin Invest 120:29-40
19. Mucke L (2009) Neuroscience: Alzheimer's disease. Nature 461:895-897
20. Ringe J, Kaps C, Burmester G-R et al (2002) Stem cells for regenerative medicine: advances
in the engineering of tissues and organs. Naturwissenschaften 89:338-351
21. Schaefer D, Klemt C, Zhang X et al (2000) Tissue engineering with mesenchymal stem cells
for cartilage and bone regeneration. Chirurg 71:1001-1008
22. Breitbach M, Bostani T, Roell W et al (2007) Potential risks of bone marrow cell
transplantation into infarcted hearts. Blood 110:1362-1369
23. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al (1998) Embryonic stem cell lines derived
from human blastocysts. Science 282:1145-1147
24. Whittaker PA (2005) Therapeutic cloning: the ethical limits. Toxicol Appl Pharmacol
207:689-691
25. Peljto M, Wichterle H (2011) Programming embryonic stem cells to neuronal subtypes.
Curr Opin Neurobiol 21:43-51 Feb 2011 Epub 20 Oct 2010
26. Canaari J, Kollet O, Lapidot T et al (2011) Neural regulation of bone, marrow, and the
microenvironment. Front Biosci (Schol Ed) 3:1021-1031, June 1
27. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse

embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676
28. Takahashi K, Okita K, Nakagawa M et al (2007) Induction of pluripotent stem cells from
fibroblast cultures. Nat Protoc 2:3081-3089
29. Wernig A, Schäfer R, Knauf U et al (2005) On the regenerative capacity of human skeletal
muscle. Artif Organs 29:192-198
30. Yu J, Vodyanik M, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived
from human somatic cells. Science 318:1917-1920